PharmaTech

APRIL 8, 2024

Extractables and leachables (E&L) testing for packaging-related impurities is essential to ensure cGMP compliance and, most importantly, patient safety.

Safety 52

Safety Patients 52

MedCity News

MARCH 13, 2023

Each year, nonprofit ECRI creates a list of the industry’s top ten patient safety concerns. This year, the pediatric mental health crisis topped the list, above other important issues like violence against healthcare staff and clinicians being expected to work outside their scope of practice.

Safety 83

Safety Patients Healthcare Healthcare 83

PharmaTech

NOVEMBER 20, 2024

Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.

Safety 40

Safety Biopharma Leads Patients 40

Pharmacy Times

SEPTEMBER 26, 2024

Issues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.

Safety 47

Safety Patients 47

MedCity News

JUNE 14, 2024

The post From Recalls to Reliability: Tools to Ensure Software Safety in MedTech appeared first on MedCity News. Cutting-edge technology empowers developers to proactively detect and mitigate issues before they cause problems, reducing recalls and fostering trust in the industry.

Safety 101

Safety Patients Medical 101

Pharmaceutical Technology

NOVEMBER 20, 2024

The Phase III BROOKLYN trial saw HeFH patients randomly assigned in a 2:1 ratio to receive either obicetrapib or a placebo for 52 weeks.

Safety 52

Safety Patients 52

European Pharmaceutical Review

OCTOBER 10, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD). Patients were 1.21 percent of quetiapine XR patients.

Safety 109

Safety Leads Patients Pharmaceutical 109

Fierce Pharma

NOVEMBER 1, 2024

An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry. | said in an interview with Fierce Pharma.

FDA 328

FDA Safety Pharma Patients 328

European Pharmaceutical Review

JULY 12, 2023

Integrated safety analysis from five prospective clinical trials for the first and only single-dose, US Food and Drug Administration (FDA)-approved microbiome -based treatment to prevent recurrent Clostridioides difficile ( C. The analysis is the largest safety evaluation to date of any microbiota-based live biotherapeutic.

Safety 98

Safety Food and Drug Administration Prospecting Food 98

Pharmacy Times

MARCH 1, 2024

Although regulation takes time, real safety concerns for patients in the rapid development of AI technology in health care are present today.

Safety 64

Safety Patients 64

MedCity News

APRIL 3, 2023

Data can help healthcare facilities improve patient safety, but first, healthcare leaders need to bring data from multiple sources together using a common taxonomy.

Safety 59

Safety Management Patients Healthcare 59

MedCity News

OCTOBER 6, 2024

Hospitals are facing increasingly burdensome policies from commercial insurers, leading to problems with cash flow and patient safety. The post Payers Are Putting Profit Over Patients with Denials and Prior Auth Policies, Hospitals Say appeared first on MedCity News.

Patients 110

Patients Insurance Safety Leads 110

MedCity News

FEBRUARY 26, 2023

Creating a category for technologies like the safety release valve would confer benefits, including improved patient safety, reduced costs for the healthcare system overall, and lowered liability risk.

Safety 90

Safety Healthcare Healthcare Patients 90

Fierce Pharma

JANUARY 25, 2024

Three months after launching an investigation into the risk of patients developing secondary T-cell cancers after receiving a CAR-T drug, the FDA has shared more information on the cases it has see | Three months after launching an investigation into the risk of secondary T-cell cancers after treatment with a CAR-T medicine, the FDA has shared more (..)

Safety 309

Safety FDA Medicine Patients 309

Fierce Pharma

DECEMBER 9, 2023

BCMA-targeted therapies are transforming care for multiple myeloma patients. But these immunotherapies also come with various potentially dangerous side effects. | A new study examined side effect reports of BMCA immunotherapies from the FDA Adverse Event Reporting System, hoping to help inform doctors in their treatment decisions.

Side effects 281

Side effects FDA Safety Doctors 281

Pharmacy Times

AUGUST 11, 2023

New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.

Safety 49

Safety Patients Prescription Medical 49

MedCity News

JANUARY 23, 2024

Two months after announcing an inquiry into reports of new cancers in patients treated with CAR T-cell therapies, the FDA is directing makers of these therapies to add new safety warnings to product labels describing this risk. Companies have 30 calendar days to comply.

Safety 96

Safety FDA Patients Biopharma 96

Veeva

APRIL 22, 2024

A robust pharmacovigilance and safety strategy is crucial, regardless of a company’s scale. Solutions like Veeva Vault Safety enable life sciences companies to bring management of safety processes in-house, with global end-to-end adverse event management on a unified platform, enabling access to real-time information.

Safety 52

Safety Management Biopharma Patients 52

Fierce Pharma

JULY 12, 2023

Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach younger patients with its JAK inhibitor cream Opzelura. Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach young patients with its JAK inhibitor cream Opzelura.

Safety 241

Safety Competition Marketing Patients 241

PharmaTimes

SEPTEMBER 21, 2023

The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes

Government 106

Government Safety Patients 106

MedCity News

AUGUST 29, 2024

Healthcare organizations tend to view issues in pockets – how they are impacting their specific organization and region – but patient safety is a collective mission. No matter what hospital or health system they are in, or which care model they belong to, patients everywhere deserve safer care.

Patients 59

Patients Safety Healthcare Healthcare 59

European Pharmaceutical Review

MAY 29, 2024

The safety and tolerability of rationally-designed live bacterial product (LBP) BMC128 combined with nivolumab has shown initial positive trends in non-small cell lung cancer (NSCLC), melanoma, or renal cell carcinoma (RCC), new data from an ongoing Phase I clinical trial suggests.

Patients 98

Patients Safety Medicine Medical 98

Pharma Marketing Network

MAY 3, 2023

However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

World of DTC Marketing

MARCH 23, 2022

Accelerated Approval allows for early access to drugs and biologics based on initial evidence of safety and effectiveness, while confirmatory studies required to verify clinical benefits are ongoing. Do patients care? The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012.

Patients 200

Patients FDA Doctors Physicians 200

Pharmacy Times

JUNE 3, 2024

Asciminib demonstrated stronger efficacy, safety, and tolerability, as well as less adverse events in patients compared with those who received investigator-selected standard-of-care tyrosine kinase inhibitors.

Safety 37

Safety Patients 37

Contrarian Sales Techniques

NOVEMBER 21, 2024

From explaining how a medication works to addressing patient concerns, reps play a vital role in bridging the gap between healthcare providers and patients. The Role of Medical Reps in Patient Education Patient education isn’t just about handing out brochures. What is Evidence-Based Medicine?

Education 52

Education Medical Patients Doctors 52

MedCity News

JANUARY 13, 2023

Nurses only strike when it’s the only option left to protect patients and deliver quality care, she declared. There’s been a recent wave of nurse strikes, but Theresa Brown — a nurse and New York Times bestselling author — said she’s never met a nurse that happily embraces striking.

Safety 105

Safety Patients 105

pharmaphorum

JULY 6, 2022

And how can regulators balance timely access with robust safety? Cancer patients in Europe wait an average of almost eight months longer for access to breakthrough medications than their American counterparts. The FDA approves new cancer treatments in half the time of the EMA – but does faster mean better? Accelerating safe access.

Safety 95

Safety FDA Medicine Patients 95

MedCity News

JULY 26, 2022

Nurses face challenges that put themselves and their patients at risk. Using closed claim data, Coverys identified nursing risk trends. A full report, including recommendations, will be released this year.

Safety 95

Safety Patients Management Healthcare 95

PharmaTimes

MAY 30, 2024

The first phase of the programme will be in place in hospitals across the UK by March 2025

Safety 98

Safety Patients Healthcare Healthcare 98

Pharmacy Times

SEPTEMBER 18, 2024

Reasons include fear of adverse effects, lack of education, polypharmacy, and others

Safety 59

Safety Medical Education Patients 59

Referral MD

OCTOBER 7, 2024

Securing Patient Portals: Best Practices for Protecting Online Records 33.33% of patient portals have privacy concerns that create a sense of distrust among many providers and patients. Implement 1-2 strategies below to better comply with privacy regulations and protect your patients against breaches.

Patients 96

Patients Healthcare Healthcare Healthcare Provider 96

Fierce Pharma

JULY 31, 2024

Three-year data from a study of early Alzheimer’s disease (AD) patients on Eisai and Biogen’s Leqembi showed that longer-term use provi | Three-year data from a study of early Alzheimer’s disease patients on Eisai and Biogen’s Leqembi showed that longer-term use provides continued benefits without additional safety concerns.

Safety 280

Safety Patients 280

Pharmacy Times

FEBRUARY 15, 2024

Experts discuss advantages of prefilled syringes in opioid delivery—reducing errors, enhancing safety, and minimizing waste—while providing insights on optimizing dosage forms.

Safety 26

Safety Patients 26

Pharmacy Times

APRIL 24, 2024

Carefully checking every piece of information and proofreading for accuracy is crucial to ensure patient safety

Safety 52

Safety Medical Patients 52

PharmaTech

JULY 5, 2022

To ensure patient safety, drug products must be tested for elemental impurities that pose risk.

Safety 52

Safety Patients 52

MedCity News

FEBRUARY 20, 2024

The FDA clinical hold follows a patient death from liver failure that may be associated with zelnecirnon, an experimental Rapt Therapeutics drug. The biotech notes that no other patient has experienced liver problems and this safety signal has not been seen in any other tests of the molecule.

FDA 98

FDA Patients Safety Biopharma 98